Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 14.59 USD | -1.35% |
|
+7.83% | +139.97% |
| Market Cap | 650M 880M 757M 712M 1.22B 83.22B 1.22B 8.44B 3.26B 42.61B 3.3B 3.23B 136B | P/E 2026 * |
-21.6x | P/E 2027 * | -17.9x |
|---|---|---|---|---|---|
| Enterprise Value | 517M 700M 602M 566M 966M 66.17B 969M 6.71B 2.59B 33.88B 2.63B 2.57B 108B | EV / Sales 2026 * |
1,591x | EV / Sales 2027 * | 634x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SLN | Delayed | |
CBOE
| SLN | Real-time | |
|
Börse Stuttgart
| XRP2 | Delayed | |
|
Tradegate
| XRP2 | Real-time | |
|
Boerse Muenchen
| XRP2 | Real-time | |
|
Deutsche Boerse AG
| XRP2 | Delayed |
Last Transcript : Silence Therapeutics plc
| 1 day | -1.35% | ||
| 1 week | +7.83% | ||
| Current month | +7.83% | ||
| 1 month | +22.09% | ||
| 3 months | +136.47% | ||
| 6 months | +134.19% | ||
| Current year | +139.97% |
| 1 week | 14.1 |  | 15.28 |
| 1 month | 13.01 | | 17.58 |
| Current year | 4.19 | | 17.58 |
| 1 year | 4.19 | | 17.58 |
| 3 years | 1.97 | | 27.72 |
| 5 years | 1.97 | | 27.72 |
| 10 years | 1.97 | | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 2025-11-30 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 2022-01-31 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 2020-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 2018-06-20 |
Iain Ross
CHM | Chairman | 72 | 2003-12-31 |
Tim McInerney
BRD | Director/Board Member | 65 | 2025-05-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/6/26 | Sell | 865,112 | 0.6105% | |||
| 1/2/26 | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 1/2/26 | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.35% | +7.83% | +156.41% | +71.65% | 878M | |
| -1.16% | -2.77% | -2.91% | +13.85% | 48.93B | |
| -0.40% | +2.16% | +418.57% | +554.47% | 45.01B | |
| -1.42% | +2.52% | +42.67% | +22.27% | 44.07B | |
| -1.22% | -0.37% | +4.82% | +84.42% | 40.73B | |
| -0.96% | -1.38% | +15.75% | +45.91% | 33.52B | |
| -0.21% | +2.86% | - | - | 17.77B | |
| -0.35% | -0.45% | +21.42% | +117.63% | 16.5B | |
| -1.54% | -1.30% | +12.16% | +31.14% | 14.67B | |
| -1.65% | +0.09% | +75.93% | +41.15% | 13.77B | |
| Average | -1.03% | +1.12% | +82.76% | +109.17% | 27.59B | |
| Weighted average by Cap. | -1.00% | -0.02% | +89.19% | +134.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 325K 440K 378K 356K 607K 41.59M 609K 4.22M 1.63M 21.3M 1.65M 1.62M 67.85M | 751K 1.02M 874K 822K 1.4M 96.13M 1.41M 9.75M 3.77M 49.23M 3.82M 3.73M 157M |
| Net income | -41.45M -56.14M -48.28M -45.41M -77.52M -5.31B -77.77M -538M -208M -2.72B -211M -206M -8.66B | -66.28M -89.77M -77.2M -72.61M -124M -8.49B -124M -861M -333M -4.35B -337M -330M -13.85B |
| Net Debt | -133M -180M -155M -146M -249M -17.05B -250M -1.73B -668M -8.73B -677M -662M -27.81B | -174M -236M -203M -191M -325M -22.29B -327M -2.26B -874M -11.42B -885M -866M -36.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$14.59 | -1.35% | 611,151 |
| 26-09-03 | US$14.79 | 0.00% | 572,406 |
| 26-09-02 | US$14.79 | +0.34% | 634,202 |
| 26-09-01 | US$14.74 | +8.94% | 1,134,889 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions
